Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In patients with IIH, abrupt cessation of GLP-1RA therapy has been reported to lead to a return of symptoms or new onset IIH in two separate case reports, highlighting the requirement of continuous therapy (22,24)
Monthly check-ins Every 4 weeks, assess whether your current frequency and dose are optimal
Prices may change depending on manufacturer supply or national demand
Trulicity (Dulaglutide): A New GLP-1 Receptor Agonist Once-Weekly Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes
Once youve met your deductible, your insurance plan will typically cover a percentage of your medical expenses through year-end, with the remainder being your responsibility to pay
US$ 22.02
US$ 22.26
US$ 25.23
US$ 28.90
